TD SELL $3454.TW at 80.93, Supp 78.50 Resis 82.53 R5 HiLo 12% T1Y 102 hold 3.0 PE 14.4 DIV 4.93% #VIVOTEK IN #Taiwan #trading #stocks …

2018-07-23
48 Views

TD SELL $3454.TW at 80.93, Supp 78.50 Resis 82.53 R5 HiLo 12% T1Y 102 hold 3.0 PE 14.4 DIV 4.93% #VIVOTEK IN #Taiwan #trading #stocks https://t.co/tLqOlakvIX


Source by TradeFlags.io

You may be interested

#Levermann #EU  #MidCap #Sell WK42 $PSON.L (4), $SMIN.L (4), $SHA.DE (4), $LEG.DE (4), $TEG.DE (4), $BDEV.L (3), $PSM.DE (3), $WCH.DE (3), $KGF.L (2), $BC8.DE (2)
Bear, Europe, Single UL Indicators
25 views
Bear, Europe, Single UL Indicators
25 views

#Levermann #EU #MidCap #Sell WK42 $PSON.L (4), $SMIN.L (4), $SHA.DE (4), $LEG.DE (4), $TEG.DE (4), $BDEV.L (3), $PSM.DE (3), $WCH.DE (3), $KGF.L (2), $BC8.DE (2)

Andreas Aigner - 2018-10-22

TOP CAPs for #Levermann #EU #MidCap #Sell WK42 $PSON.L (4), $SMIN.L (4), $SHA.DE (4), $LEG.DE (4), $TEG.DE (4), $BDEV.L (3),…

#Levermann #EU  #BigCap #Sell WK42 $FP.PA (2), $OR.PA (2), $GSK.L (2), $ALV.DE (2), $AIR.PA (2), $ADS.DE (2), $CON.DE (2), $AAL.L (2), $CRH.L (2), $DB1.DE (2)
Bear, Europe, Single UL Indicators
26 views
Bear, Europe, Single UL Indicators
26 views

#Levermann #EU #BigCap #Sell WK42 $FP.PA (2), $OR.PA (2), $GSK.L (2), $ALV.DE (2), $AIR.PA (2), $ADS.DE (2), $CON.DE (2), $AAL.L (2), $CRH.L (2), $DB1.DE (2)

Andreas Aigner - 2018-10-22

TOP CAPs for #Levermann #EU #BigCap #Sell WK42 $FP.PA (2), $OR.PA (2), $GSK.L (2), $ALV.DE (2), $AIR.PA (2), $ADS.DE (2),…

#Levermann #EU  #BigCap #Buy WK42 $NXT.L (5), $ASML.AS (4), $SAF.PA (4), $IAG.L (4), $PSN.L (4)
Bull, Europe, Single UL Indicators
23 views
Bull, Europe, Single UL Indicators
23 views

#Levermann #EU #BigCap #Buy WK42 $NXT.L (5), $ASML.AS (4), $SAF.PA (4), $IAG.L (4), $PSN.L (4)

Andreas Aigner - 2018-10-22

TOP CAPs for #Levermann #EU #BigCap #Buy WK42 $NXT.L (5), $ASML.AS (4), $SAF.PA (4), $IAG.L (4), $PSN.L (4)

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.